Analysis of the causes of lethal outcome in patients infected with human immunodeficiency virus
- Authors: Tukhasheva F.Y.1, Markova A.V.1, Zhelobov V.G.1, Goryacheva O.G.1, Malelin E.G.1, Mekhonoshin K.D.1
-
Affiliations:
- Ye. A. Vagner Perm State Medical University
- Issue: Vol 42, No 4 (2025)
- Pages: 55-63
- Section: Literature review
- Submitted: 18.02.2025
- Published: 11.09.2025
- URL: https://permmedjournal.ru/PMJ/article/view/656658
- DOI: https://doi.org/10.17816/pmj42455-63
- ID: 656658
Cite item
Abstract
Over 37 million HIV-infected people live in the world and many of them die due to the progression and decompensation of somatic diseases. The aim of the study is to determine the rating of fatal outcomes causes of HIV-infected patients according to the data of the authors from different countries of the world.
Data from 287 full-text articles were analyzed, from which 32 sources most relevant to the purpose of the study were selected. The leading causes of death in HIV-infected patients were infectious complications and opportunistic infections characteristic of the AIDS stage, along with concomitant tuberculosis infection (55.1 %). Cardiovascular diseases ranked second (20.6 %), followed by cancer (14.6 %), liver diseases, including alcoholic and viral hepatitis and cirrhosis (8.5 %), and only 1.1% are accounted for by all other diseases. Mortality from infective endocarditis, myocardial infarction, sudden cardiac death, acute cerebrovascular event, pulmonary embolism and acute decompensation of chronic heart failure together account for 82.5 % of all cardiovascular causes of mortality.
Monitoring of patients with HIV infection should be comprehensive, involving infectious disease specialists, therapeutic and cardiology services, with increased cancer vigilance. The challenges of HIV infection concerning early development of cardiovascular pathology and elevated mortality from cardiovascular diseases should not be ignored.
Full Text
Introduction
More than 37 million people worldwide are living with HIV, and many of them die as a result of the development and decompensation of somatic diseases [1]. The prevalence of somatic diseases among HIV-infected individuals contributes significantly to disability and mortality both globally [2] and in the Russian Federation [3]. The availability of modern electronic libraries allows us to analyze the causes of death in patients with HIV infection.
The aim of the study is to determine the main causes of death among HIV-infected patients based on data from various studies.
Materials and Methods
A group of researchers analyzed full-text articles in the electronic search engines PubMed, Google Scholar, and Elibrary using the keywords: HIV, mortality, cause of death. A total of 287 sources were identified. Subsequently, 28 studies that best corresponded to the research objective were selected. Studies conducted on animals or in pediatrics were not included in the study. The following aspects of the problem were analyzed: ranking of the most common causes of death and ranking of possible diseases within the cause of death from cardiovascular pathology. The average frequency of fatalities was determined using Microsoft Excel tables, and the significance of the differences between the average values was calculated using the Review Manager program.
Results and Discussion
According to data from a Swiss cohort study, only 9.0 % of deaths among HIV-infected individuals are associated with acquired immunodeficiency syndrome (AIDS) against a background of opportunistic infections, 22.9 % are due to causes unrelated to AIDS and cancer, 10.2 % of deaths are associated with the development of liver failure, and 9.7 % of deaths occur due to decompensation of cardiovascular diseases [4]. At the same time, according to data from a joint American and European registry, AIDS, cancer, and cardiovascular disease are the leading causes of death among HIV-infected individuals [5]. The incidence of sudden cardiac death among HIV-infected individuals is significantly higher than among people without HIV [6].
According to M. Farahani et al., cardiovascular disease is the most common cause of death in HIV-infected patients, apart from death from AIDS [7]. The study by J. Chelli et al. (2016) indicates that in 44.4 % of cases, the cause of death in HIV-infected patients is opportunistic infections as a manifestation of the AIDS stage, mainly pneumonia [8]. Among HIV-infected patients undergoing inpatient treatment for various reasons, sudden cardiac death and decompensation of cardiovascular diseases as the cause of death occurred in 43.51 % of cases [9]. According to V.A. Narla et al. (2021), the incidence of sudden cardiac death among patients with HIV infection and chronic heart failure (CHF) is 21 % [10]. In 21.8 % of cases, fatal outcomes are observed in HIV-infected patients diagnosed with tuberculosis coinfection [11]. The study by M.S. Freiberg et al. (2021) showed that among patients with HIV infection, there were fewer cases of illness and death from chronic diseases of the tracheobronchial tree and diabetes mellitus than among patients without HIV infection [12].
Based on the results of various studies from different countries around the world and calculations of average mortality rates, it was possible to obtain an overall picture of the spectrum of causes of mortality in patients with
HIV infection (Table 1). While infectious complications and opportunistic infections characteristic of the AIDS stage, as well as associated tuberculosis infection, traditionally rank first (55.1 %), cardiovascular diseases rank second, accounting for a total of about 20.6 %. Slightly less common causes of death are cancer (14.6 %), liver disease, including alcoholic and viral hepatitis and cirrhosis (8.5 %), and only 1.1 % are all other diseases.
Table 1. The main causes of death in patients with HIV infection according to clinical studies by authors from different countries
Cause of death | Author | Country | Prevalence, % | Number of patients / deaths |
AIDS and opportunistic infections | Weber, 2024 Trickey, 2024 Chelli, 2016 | Switzerland United States Tunisia | 9.0 25.0 44.4 | 1630/47 16897/4222 54/24 |
Oncology | Weber, 2024 Trickey, 2024 Chelli, 2016 Yakovlev, 2015 | Switzerland United States Tunisia Russia | 22.9 13.7 9.2 13.5 | 1630/166 16897/2314 54/ 5 52/7 |
Hepatic insufficiency | Weber, 2024 | Switzerland United States
| 10.2 6.9 | 1630/166 16897/ 1167 |
Decompensation of CVD and sudden cardiac death | Weber, 2024 Trickey, 2024 Tseng, 2021 Narla, 2021 | Switzerland The USA The USA The USA
| 9.7 8.3 43.5 21.0 | 1630 / 158 16897/1406 610 / 265 344 / 72 |
Tuberculosis of various locations | Lelisho, 2023 Yakovlev, 2015 | Spain Russia | 21.8 36.5 | 363/79 52/19 |
Note: AIDS – acquired immunodeficiency syndrome, CVD – cardiovascular disease.
While a specialized system of AIDS centers is actively involved in the diagnosis and treatment of infectious diseases and complications associated with HIV infection in Russia, the diagnosis and treatment of cardiovascular disease, liver disease, and cancer are primarily the responsibility of primary health care organizations. The latter requires the development of additional clinical algorithms for diagnosis, treatment, identification of risk factors, and target organs of the disease.
The main diseases of the cardiovascular system – causes of death in patients with HIV infection – are analyzed separately in this study, as this pathology requires a clinical approach that differs from that of an infectious disease specialist. Cardiovascular diseases are the cause of death in 20.6 % of HIV-infected patients. An analysis of the spectrum of cardiovascular diseases – causes of death in HIV patients – was conducted based on data from the current literature.
Table 2 presents a sample of cardiovascular causes of death in HIV-infected patients.
Table 2. Major cardiovascular diseases – causes of death in patients with HIV infection according to clinical studies by authors from different countries
Cause of death | Author | Country | Prevalence, % | Number of patients / deaths |
Sudden cardiac death | Narla, 2021 Tseng, 2021 Freiberg, 2021 Basel, 2021 | The USA The USA The USA The USA
| 21 0.05 1.75 1 | 2578/540 100000/53,3 44407/777 2860/30 |
Myocardial infarction | Hsue, 2019 Protasov, 2024 | The USA Russia | 5 34 | 189/9 2464/842 |
ACHF and AHF | Bredy, 2016 Abeya, 2018 | The USA The USA
| 2.6 43 | 685/18 216/ 93 |
PTE | Alvaro-Meca, 2018 | Spain
| 12.2 | 1356/1120 |
ACIS | Alvaro-Meca, 2018 Silva-Pinto, 2018 | Spain England | 2.3 13 | 1356/32 23/3 |
Infectious endocarditis | Belyakov, 2016 Muñoz-Moreno, 2019 | Russia Spain
| 17.2 51.4 | 1500/360 1439/290 |
Note: ACHF – acute decompensation of chronic heart failure, AHF – acute heart failure, ACIS – acute cerebrovascular accident, PTE – pulmonary thromboembolism
It has been found that infectious endocarditis is the leading cardiovascular cause of death among HIV-infected individuals [13; 14]. The second leading cause of death is acute decompensation of CHF or acute heart failure [15; 16]. Myocardial infarction ranks third among causes of death in HIV-infected individuals [17; 18]. Less common causes of death include pulmonary embolism [19], stroke [19; 20], and sudden cardiac death [9; 10; 12; 21].
According to the data obtained, death from infectious endocarditis, myocardial infarction, sudden cardiac death, acute cerebrovascular accident, pulmonary embolism, and acute decompensation of chronic heart failure together account for 82.5 % of all cardiovascular causes of mortality. Other causes account for no more than 17.5 %.
A comparative meta-analysis of deaths from AIDS and opportunistic infections was conducted in comparison with deaths from cardiovascular causes based on the results of a survey of 19,535 patients, whose observation data are described in five clinical studies (Figure, a).
Fig. Comparative meta-analysis of causes of death among HIV-infected individuals: a – from AIDS and opportunistic infections and death from cardiovascular disease; b – from cardiovascular disease and cancer
The study found that deaths from AIDS and opportunistic infections were the leading cause of death among HIV-infected patients, compared to deaths from cardiovascular disease (р = 0.034).
According to the data obtained, when comparing cardiovascular and oncological causes of death in HIV-infected patients, cardiovascular causes prevail over oncological pathology (р < 0.001) (Figure, b).
Thus, we analyzed the causes of death among HIV-infected patients by combining data from 20 studies involving 177,668 HIV-positive patients, among whom 7,804 deaths (4.39 %) were recorded during a follow-up period ranging from 10 days to 6 months. Our analysis showed that HIV-infected individuals die more often from AIDS (26.1 %), HIV + tuberculosis coinfection (29.1 %), and cardiovascular events (20.6 %) than from other causes. People living with HIV are among the most vulnerable patient groups and require increased attention from healthcare professionals. The results obtained emphasize the importance of involving cardiology and therapeutic specialists in the dispensary observation of HIV-infected patients in order to prevent the premature development of adverse endpoints – death from cardiovascular causes.
According to contemporary authors, the incidence of sudden cardiac death is significantly higher among people with HIV infection and concomitant CHF, while effective antiretroviral therapy and timely diagnosis can protect people living with HIV from sudden cardiac death and decompensation of cardiovascular diseases [22].
High mortality rates are observed in cases of HIV + tuberculosis co-infection. Much evidence indicates that HIV-positive patients have socio-demographic factors that contribute to the development of tuberculosis infection, and immunosuppression only exacerbates the situation [23; 24]. Low CD4 T-lymphocyte counts and unsuppressed viral load correlate more strongly with death from all causes in HIV-infected individuals, as well as from cardiovascular disease. It is known that HIV replication is an iron-dependent process, and an increase in non-transferrin-bound iron levels is associated with the risk of opportunistic infections, while the severity of anemia correlates with a high risk of death in HIV-infected individuals from all causes, regardless of whether they are related to CHF or not [25; 26]. Among the factors indicating imminent death in HIV-infected individuals are the development of severe thrombocytopenia [27; 28], alcoholic cardiomyopathy [29; 30], a decrease in glomerular filtration rate below 60 ml/min/1.73 m2 [31], and a low body mass index [32]. Given the significance of cardiovascular disease among the leading causes of mortality in HIV-infected patients, early preventive cardiological examination and monitoring of symptoms and signs of cardiovascular disease are recommended.
Conclusions
AIDS, opportunistic infections, and tuberculosis are the leading causes of death among HIV-infected patients, according to scientists from various countries around the world. Cardiovascular diseases are the second leading cause of death. Cancer closes out the top three causes of death. The monitoring of HIV-infected patients should be carried out comprehensively, involving infectious disease specialists, therapeutic and cardiological services, with increased cancer awareness. The challenges of HIV infection in terms of the early development of cardiovascular pathology and the high number of deaths from cardiovascular diseases cannot be ignored.
About the authors
F. Ya. Tukhasheva
Ye. A. Vagner Perm State Medical University
Email: o.goryacheva@mail.ru
ORCID iD: 0009-0007-2157-8361
6th-year Student of the Faculty of Medicine
Russian Federation, PermA. V. Markova
Ye. A. Vagner Perm State Medical University
Email: o.goryacheva@mail.ru
ORCID iD: 0009-0004-9105-481X
6th-year Student of the Faculty of Medicine
Russian Federation, PermV. G. Zhelobov
Ye. A. Vagner Perm State Medical University
Email: zhelobov.v@yandex.ru
ORCID iD: 0000-0003-0780-3116
DSc (Medicine), Professor, Head of the Department of Polyclinic Therapy
Russian Federation, PermO. G. Goryacheva
Ye. A. Vagner Perm State Medical University
Author for correspondence.
Email: o.goryacheva@mail.ru
ORCID iD: 0000-0002-3336-229X
PhD (Medicine), Associate Professor of the Department of Polyclinic Therapy
Russian Federation, PermE. G. Malelin
Ye. A. Vagner Perm State Medical University
Email: o.goryacheva@mail.ru
ORCID iD: 0009-0003-8837-9376
6th-year Student of the Faculty of Medicine
Russian Federation, PermK. D. Mekhonoshin
Ye. A. Vagner Perm State Medical University
Email: o.goryacheva@mail.ru
ORCID iD: 0009-0001-7259-9759
6th-year Student of the Faculty of Medicine
Russian Federation, PermReferences
- Li X. HIV infection and risk of heart failure: A meta-analysis and systematic review. Acta Biochim Pol. 2022; 69 (3): 531–535.
- Freiberg M.S., Chang C.H., Skanderson M., et al. Association Between HIV infection and the risk of heart failure with reduced ejection fraction and preserved ejection fraction in the antiretroviral therapy era: Results from the veterans aging cohort study. JAMA Cardiol. 2017; 2 (5): 536–546.
- Шеховцeва Т.А., Дупляков Д.В. ВИЧ-инфекция и патология сердечно-сосудистой системы. Кардиоваскулярная терапия и профилактика 2023; 22 (3): 3370. / Shekhovtsova T.A., Duplyakov D.V. HIV infection and cardiovascular pathology. Cardiovascular Therapy and Prevention 2023; 22 (3): 3370 (in Russian).
- Weber M.S.R., Duran Ramirez J.J., Hentzien M., Cavassini M., Bernasconi E., Hofmann E., et al. HIV cohort study. Time trends in causes of death in people with HIV: Insights from the swiss HIV cohort study. Clin Infect Dis. 2024; 79 (1): 177–188.
- Trickey A., McGinnis K., Gill M.J., Abgrall S., Berenguer J., Wyen C., et al. Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies. Lancet HIV 2024; 11 (3): e176-e185.
- Perkins M.V., Joseph S.B., Dittmer D.P., et al. Cardiovascular disease and thrombosis in HIV infection. Arterioscler Thromb Vasc Biol. 2023; 43 (2): 175–191.
- Farahani M., Mulinder H., Farahani A. Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis. Int J STD AIDS 2017; 28 (7): 636–650.
- Chelli J., Bellazreg F., Aouem A., et al. Causes de décès des patients infectés par le VIH dans le Centre tunisien [Causes of death in patients with HIV infection in two Tunisian medical centers]. Pan Afr Med J. 2016; 25: 105.
- Tseng Z.H., Moffatt E., Kim A., et al. Sudden cardiac death and myocardial fibrosis, determined by autopsy, in persons with HIV. N Engl J Med. 2021; 384 (24): 2306–2316.
- Narla V.A. Sudden cardiac death in HIV-infected patients: A contemporary review. Clin Cardiol. 2021; 44 (3): 316–321.
- Lelisho M.E., Teshale B.M., Tareke S.A., et al. Modeling survival time to death among TB and HIV Co-infected adult patients: An institution-based retrospective cohort study. J Racial Ethn Health Disparities 2023; 10 (4): 1616–1628.
- Freiberg M.S., Duncan M.S., Alcorn C., et al. HIV infection and the risk of world health organization – defined sudden cardiac death. J Am Heart Assoc. 2021; 10 (18): e021268.
- Беляков Н.А., Рассохин В.В., Трофимова Т.Н. и др. Коморбидные и тяжелые формы ВИЧ-инфекции в россии. ВИЧ-инфекция и иммуносупрессии. 2016; 8 (3): 9–25. / Belyakov N.A., Rassokhin V.V., Trofimova T.N., et al. Advanced and comorbid HIV cases in Russia. J. HIV Infection and Immunosuppressive Disorders 2016; 8 (3): 9–25 (in Russian).
- Cysique L.A., Levin J., Howard C., et al. NeuroHIV and aging advocacy group. Fostering healthy cognitive ageing in people living with HIV. Lancet HIV 2025; 12 (1): e71-e80.
- Abeya F.C., Lumori B.A.E., Akello S.J., et al. Incidence and predictors of 6 months mortality after an acute heart failure event in rural Uganda: The Mbarara Heart Failure Registry (MAHFER). Int J Cardiol. 2018; 264: 113–117.
- Pierre-Louis B., Rodriques S., Gorospe V., Guddati A.K., Aronow W.S., Ahn C., Wright M. Clinical factors associated with early readmission among acutely decompensated heart failure patients. Arch Med Sci. 2016; 12 (3): 538–45.
- Hsue P.Y., Waters D.D. HIV infection and coronary heart disease: mechanisms and management. Nat Rev Cardiol. 2019; 16 (12): 745–759.
- Протасов К.В., Енисеева Е.С., Плотникова Ю.К. Инфаркт миокарда у пациентов с ВИЧ-инфекцией: заболеваемость, факторы риска, особенности патогенеза, клиники и лечения. Российский кардиологический журнал 2024. 29 (1S): 5670. / Protasov K.V., Eniseeva E.S., Plotnikova Yu.K. Myocardial infarction in patients with HIV infection: incidence, risk factors, pathogenesis, clinical performance and treatment. Russian Journal of Cardiology 2024; 29 (1S): 5670 (in Russian).
- Alvaro-Meca A., Ryan P., Micheloud D., De Miguel A., Berenguer J., Resino S. Trends in pulmonary embolism in patients infected with HIV during the combination antiretroviral therapy era in Spain: A nationwide population-based study. Sci Rep. 2018 14; 8 (1): 12137.
- Silva-Pinto A., Costa A., Serrão R., Sarmento A., Abreu P. Ischaemic stroke in HIV-infected patients: a case-control study. HIV Med. 2017; 18 (3): 214–219.
- Abdelazeem B., Gergis K., Baral N., Rauniyar R., Adhikari G. Sudden cardiac death and sudden cardiac arrest in patients with human immunodeficiency virus: A systematic review. Cureus. 2021; 13 (3): e13764.
- Edge C.L., King E.J., Dolan K., McKee M. Prisoners co-infected with tuberculosis and HIV: a systematic review. J Int AIDS Soc. 2016; 19 (1): 20960.
- Яковлев А.А., Мусатов В.Б., Савченко М.А. Причины летальных исходов у ВИЧ-инфицированных пациентов, получающих антиретровирусную терапию. ВИЧ-инфекция и иммуносупрессии 2015; 7 (1): 84–89. / Yakovlev A.A., Musatov V.B., Savchenko M.A. Causes of death among HIV infected patients receiving antiretroviral therapy. J. HIV Infection and Immunosuppressive Disorders 2015; 7 (1): 84–89 (in Russian).
- Abioye A.I., Andersen C.T., Sudfeld C.R., Fawzi W.W. Anemia, iron status, and HIV: A systematic review of the evidence. Adv Nutr. 2020; 11 (5): 1334–1363.
- Obeagu E.I., Obeagu G.U., Ukibe N.R., et al. Anemia, iron, and HIV: decoding the interconnected pathways: A review. Medicine (Baltimore) 2024; 103 (2): e36937.
- Alvi R.M., Neilan A.M., Tariq N., et al. The risk for sudden cardiac death among patients living with heart failure and human immunodeficiency virus. JACC Heart Fail. 2019; 7 (9): 759–767.
- Горячева О.Г. Особенности хронической сердечной недостаточности на фоне тромбоцитопении у лиц, инфицированных вирусом иммунодефицита человека. Сибирский журнал клинической и экспериментальной медицины 2024; 39 (1): 126–134. / Goryacheva O.G. Features of chronic heart failure on the background of thrombocytopenia in persons infected with the human immunodeficiency virus. Siberian Journal of Clinical and Experimental Medicine 2024; 39 (1): 126–134 (in Russian).
- Fernández-Solà J. The effects of ethanol on the heart: alcoholic cardiomyopathy. Nutrients 2020; 12 (2): 572.
- Горячева О.Г., Терехина Н.А., Терехин Г.А. Влияние алкогольной зависимости на течение хронической сердечной недостаточности у больных с ВИЧ-инфекцией. Уральский медицинский журнал 2023; 22 (6): 104−112. / Goryacheva O.G., Terekhina N.A., Terekhin G.A. The influence of alcohol dependence on the course of chronic heart failure in patients with HIV infection. Ural Medical Journal 2023; 22 (6): 104−112 (in Russian).
- Lawson C.A., Testani J.M., Mamas M., Damman K., Jones P.W., Teece L., Kadam U.T. Chronic kidney disease, worsening renal function and outcomes in a heart failure community setting: A UK national study. Int J Cardiol. 2018; 267: 120–127.
- Choi H., Dey A.K., Sharma G., et al. Etiology and pathophysiology of heart failure in people with HIV. Heart Failure Reviews 2021; 26 (3): 497–505.
- Feinstein M.J., Hsue P.Y., Benjamin L.A., et al. Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association. Circulation 2019; 140 (2): e98124.
Supplementary files
Note
Over 37 million HIV-infected people live in the world and many of them die due to the progression and decompensation of somatic diseases. The aim of the study is to determine the rating of fatal outcomes causes of HIV-infected patients according to the data of the authors from different countries of the world.
Data from 287 full-text articles were analyzed, from which 32 sources most relevant to the purpose of the study were selected. The leading causes of death in HIV-infected patients were infectious complications and opportunistic infections characteristic of the AIDS stage, along with concomitant tuberculosis infection (55.1 %). Cardiovascular diseases ranked second (20.6 %), followed by cancer (14.6 %), liver diseases, including alcoholic and viral hepatitis and cirrhosis (8.5 %), and only 1.1% are accounted for by all other diseases. Mortality from infective endocarditis, myocardial infarction, sudden cardiac death, acute cerebrovascular event, pulmonary embolism and acute decompensation of chronic heart failure together account for 82.5 % of all cardiovascular causes of mortality.
Monitoring of patients with HIV infection should be comprehensive, involving infectious disease specialists, therapeutic and cardiology services, with increased cancer vigilance. The challenges of HIV infection concerning early development of cardiovascular pathology and elevated mortality from cardiovascular diseases should not be ignored.


